Funding for this research was provided by:
National Cancer Institute (T32-CA-236621)
Received: 21 September 2021
Accepted: 10 February 2022
First Online: 16 February 2022
: The local Institutional Review Board was deemed exempt from ongoing oversight; the study involved no direct contact with participants, and survey responses were not linked to potential personal identifier.
: Participants provided electronic consent for their participation and did not receive any financial incentive for completing the survey.
: Not applicable; confidentiality is assured for all participants regarding any personal responses and information provided, as all data collected were anonymized.
: All authors do not have any conflicts to disclose.